| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Hideaki Hara | |
| Masamitsu Shimazawa | |||
| Yasushi Ito | |||
| P2860 | cites work | Ganglion cell death in glaucoma: what do we really know? | Q24673200 |
| Neurotrophin-regulated signalling pathways | Q24678332 | ||
| Glutamate as a neurotransmitter in the brain: review of physiology and pathology | Q28139934 | ||
| S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration | Q28242222 | ||
| Retinal projections in mice with inherited retinal degeneration: implications for circadian photoentrainment | Q30472181 | ||
| Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data | Q30580986 | ||
| Optic nerve blood-flow abnormalities in glaucoma | Q32042440 | ||
| Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells | Q32064564 | ||
| Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures | Q33205224 | ||
| Involvement of ER stress in retinal cell death | Q33282259 | ||
| Glaucoma alters the circadian timing system | Q33392705 | ||
| Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage | Q72633267 | ||
| Ganglion cell loss after optic nerve crush mediated through AMPA-kainate and NMDA receptors | Q73234866 | ||
| Retrograde axonal transport impairment of large- and medium-sized retinal ganglion cells in diabetic rat | Q73317431 | ||
| Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases | Q73419640 | ||
| N(omega)-nitro-L-arginine methyl ester protects retinal neurons against N-methyl-D-aspartate-induced neurotoxicity in vivo | Q73467169 | ||
| Lomerizine, a Ca2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina | Q73922338 | ||
| Nitric oxide, microglial activities and neuronal cell death in the lateral geniculate nucleus of glaucomatous rats | Q74340328 | ||
| Necrosis and apoptosis after retinal ischemia: involvement of NMDA-mediated excitotoxicity and p53 | Q74586640 | ||
| Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve | Q74819296 | ||
| Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia | Q77510870 | ||
| Retinal vulnerability to glutamate excitotoxicity in canine glaucoma: induction of neuronal nitric oxide synthase in retinal ganglion cells | Q77627443 | ||
| [Functional alterations of astroglia on brain pathologies and their intracellular mechanisms] | Q77825069 | ||
| Effect of lomerizine, a new Ca(2+)channel blocker, on the microcirculation in the optic nerve head in conscious rabbits: a study using a laser speckle technique | Q78088246 | ||
| N-methyl-D-aspartate (NMDA)--induced apoptosis in rat retina | Q78221882 | ||
| Ocular blood flow and glaucoma | Q81820968 | ||
| Glaucoma, apoptosis, and neuroprotection. | Q33575714 | ||
| N-methyl-D-aspartate receptors contribute to excitatory postsynaptic potentials of cat lateral geniculate neurons recorded in thalamic slices | Q33633233 | ||
| Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma | Q33693579 | ||
| Disorders of the pupil | Q34259621 | ||
| Excitatory amino acids as a final common pathway for neurologic disorders. | Q34321926 | ||
| Clinical potential of lomerizine, a Ca2+ channel blocker as an anti-glaucoma drug: effects on ocular circulation and retinal neuronal damage | Q34360123 | ||
| Mouse models of retinal ganglion cell death and glaucoma | Q34664035 | ||
| The impact of ocular blood flow in glaucoma | Q34768692 | ||
| Neurotrophin signaling through the p75 neurotrophin receptor | Q34778209 | ||
| Multifaceted roles of nitric oxide in the lateral geniculate nucleus: from visual signal transduction to neuronal apoptosis | Q35082313 | ||
| Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex | Q35769429 | ||
| Neurone-to-astrocyte signalling in the brain represents a distinct multifunctional unit. | Q35817626 | ||
| Animal models of optic nerve diseases | Q35944010 | ||
| Astrocyte metabolism and signaling during brain ischemia | Q36983687 | ||
| Ganglion cell death in glaucoma: from mice to men. | Q36987266 | ||
| Atrophy of the lateral geniculate nucleus in human glaucoma detected by magnetic resonance imaging | Q37019659 | ||
| The neurobiology of cell death in glaucoma | Q37044571 | ||
| Number of people with glaucoma worldwide | Q37320324 | ||
| Differential central distribution of optic nerve components in the rat | Q39403141 | ||
| Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey | Q39432089 | ||
| Excitatory amino acid receptors and synaptic transmission in the rat ventrobasal thalamus | Q41346334 | ||
| Selective blockade of non-NMDA receptors does not block rapidly triggered glutamate-induced neuronal death | Q41684419 | ||
| A proposed role for excitotoxicity in glaucoma | Q41716801 | ||
| Free radicals in retinal ischemia | Q41724634 | ||
| Neuroprotective effect of calcium channel blocker against retinal ganglion cell damage under hypoxia | Q42168781 | ||
| Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressure | Q42599609 | ||
| The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain | Q42660952 | ||
| The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma | Q42748164 | ||
| Involvement of brain-derived neurotrophic factor in time-dependent neurodegeneration in the murine superior colliculus after intravitreal injection of N-methyl-D-aspartate. | Q42968438 | ||
| Lomerizine, a Ca2+ channel blocker, protects against neuronal degeneration within the visual center of the brain after retinal damage in mice | Q43269665 | ||
| Influence of low IOP and low calcium on retrograde axoplasmic transport in rat optic nerve in vitro | Q43583057 | ||
| Interleukin-1beta mediates ischemic injury in the rat retina | Q43826198 | ||
| Synaptic distribution of ionotropic glutamate receptors in the inner plexiform layer of the primate retina | Q43971746 | ||
| Brain-derived neurotrophic factor inhibits changes in soma-size of retinal ganglion cells following optic nerve axotomy in rats | Q44051309 | ||
| Brain-derived neurotrophic factor prevents axotomized retinal ganglion cell death through MAPK and PI3K signaling pathways. | Q44161089 | ||
| Divergent NMDA signals leading to proapoptotic and antiapoptotic pathways in the rat retina | Q44265574 | ||
| Protective effect of KB-2796, a new calcium antagonist, in cerebral hypoxia and ischemia | Q44371144 | ||
| Memantine in moderate-to-severe Alzheimer's disease | Q44388745 | ||
| Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease. | Q44932588 | ||
| Phenytoin protects against ischemia-produced neuronal cell death | Q45031337 | ||
| Memantine protects against secondary neuronal degeneration in lateral geniculate nucleus and superior colliculus after retinal damage in mice. | Q45138275 | ||
| Nucleus- and cell-specific expression of NMDA and non-NMDA receptor subunits in monkey thalamus | Q46320932 | ||
| Degenerative alterations in the visual pathway after NMDA-induced retinal damage in mice | Q46623795 | ||
| Structural and functional composition of the developing retinogeniculate pathway in the mouse | Q46839109 | ||
| N-Methyl-D-Aspartic acid suppresses Akt activity through protein phosphatase in retinal ganglion cells. | Q46886388 | ||
| Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine. | Q46922833 | ||
| Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma | Q46943229 | ||
| A new calcium channel antagonist, lomerizine, alleviates secondary retinal ganglion cell death after optic nerve injury in the rat. | Q46986519 | ||
| BDNF attenuates retinal cell death caused by chemically induced hypoxia in rats. | Q48141434 | ||
| Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. | Q48148427 | ||
| Effect of KB-2796, a new diphenylpiperazine Ca2+ antagonist, on glutamate-induced neurotoxicity in rat hippocampal primary cell cultures | Q48316038 | ||
| Mediation of thalamic sensory input by both NMDA receptors and non-NMDA receptors | Q48320599 | ||
| Inhibition of the retrograde axonal transport of dopamine-beta-hydroxylase antibodies by the calcium ionophore A23187. | Q48445589 | ||
| Bifemelane protects cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity | Q48466506 | ||
| Depth segregation of retinal ganglion cells projecting to mouse superior colliculus | Q48495742 | ||
| Axotomy-induced neuronal death and reactive astrogliosis in the lateral geniculate nucleus following a lesion of the visual cortex in the rat. | Q48505155 | ||
| The role of neuronal and endothelial nitric oxide synthase in retinal excitotoxicity. | Q48618583 | ||
| Retinal ganglion cells that project to the superior colliculus and pretectum in the macaque monkey | Q48638119 | ||
| Retinal ganglion cells that project to the dorsal lateral geniculate nucleus in the macaque monkey | Q48638129 | ||
| Blockade of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vivo adult mammalian retina | Q48699234 | ||
| Genetic and environmental control of variation in retinal ganglion cell number in mice | Q48860500 | ||
| Synaptic patterns of the superficial layers of the superior colliculus of the rat. | Q49071395 | ||
| Infusion of (+) -MK-801 and memantine -- contrasting effects on radial maze learning in rats with entorhinal cortex lesion | Q49119572 | ||
| Calcium channel activation facilitated by nitric oxide in retinal ganglion cells. | Q51422768 | ||
| Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. | Q54109564 | ||
| Electrophysiological and morphological evidence for a diameter-based innervation pattern of the superior colliculus | Q54378777 | ||
| Metallothionein, an endogenous antioxidant, protects against retinal neuron damage in mice. | Q54585652 | ||
| Fixation and orientation control by the tecto-reticulo-spinal system in the cat whose head is unrestrained | Q57043863 | ||
| Influence of nifedipine on the visual fields of patients with optic-nerve-head diseases | Q57103564 | ||
| Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man. | Q57781109 | ||
| N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina | Q68126319 | ||
| Protective effects of flunarizine on ischemic injury in the rat retina | Q68140166 | ||
| [Acute effects of 1-[bis(4-fluorophenyl)methyl]-4-(2,3,4-trimethoxybenzyl) piperazine dihydrochloride, KB-2796, on cerebral blood flow in unanesthetized cats] | Q69012660 | ||
| The effect of Ca2(+) -antagonist on visual field in low-tension glaucoma | Q69782829 | ||
| Calcium channel blockers in the management of low-tension and open-angle glaucoma | Q70704896 | ||
| A behavioral model of excitotoxicity: retinal degeneration, loss of vision, and subsequent recovery after intraocular NMDA administration in adult rats | Q70841158 | ||
| Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma | Q70985111 | ||
| Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma | Q70999763 | ||
| Brain-derived neurotrophic factor and neurotrophin-4/5 stimulate growth of axonal branches from regenerating retinal ganglion cells | Q71132184 | ||
| Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine | Q71174060 | ||
| The superior colliculus and movements of the head and eyes in cats | Q71505267 | ||
| Effects of Ca2+ channel blockers on directional selectivity of rabbit retinal ganglion cells | Q71511201 | ||
| Brain-derived neurotrophic factor (BDNF) prevents lesion-induced axonal die-back in young rat optic nerve | Q71704603 | ||
| Effects of a new diphenylpiperazine calcium antagonist, KB-2796, on cerebral ischemic neuronal damage in rats | Q72252941 | ||
| The requirement for calcium ions and the effect of other ions on axoplasmic transport in mammalian nerve | Q72616437 | ||
| P433 | issue | 5 | |
| P921 | main subject | excitotoxicity | Q901117 |
| P304 | page(s) | e169-79 | |
| P577 | publication date | 2010-06-11 | |
| P1433 | published in | CNS Neuroscience & Therapeutics | Q5013184 |
| P1476 | title | REVIEW: An approach for neuroprotective therapies of secondary brain damage after excitotoxic retinal injury in mice | |
| P478 | volume | 16 |
Search more.